Supernus Pharmaceuticals, Inc. (SUPN)
NASDAQ: SUPN · Real-Time Price · USD
31.96
-0.04 (-0.11%)
Mar 6, 2025, 10:57 AM EST - Market open
Supernus Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Net Income | 73.87 | 1.32 | 60.71 | 53.42 | 126.95 | Upgrade
|
| Depreciation & Amortization | 80.41 | 84.86 | 85.54 | 32.6 | 18.14 | Upgrade
|
| Other Amortization | - | 0.53 | 2.11 | 17.5 | 16.58 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | 20.19 | - | 15 | - | Upgrade
|
| Loss (Gain) From Sale of Investments | 1.81 | -0.12 | 3.22 | 0.07 | -7.24 | Upgrade
|
| Loss (Gain) on Equity Investments | - | - | -12.89 | - | - | Upgrade
|
| Stock-Based Compensation | 27.76 | 26.76 | 17.57 | 17.91 | 16.56 | Upgrade
|
| Other Operating Activities | -9.85 | -13.31 | -15.2 | -12.94 | 3.92 | Upgrade
|
| Change in Accounts Receivable | 2.08 | 18.77 | -16.37 | 3.87 | -34.61 | Upgrade
|
| Change in Inventory | 15.81 | 6.11 | -17.86 | -14.58 | -10.12 | Upgrade
|
| Change in Accounts Payable | -15.02 | -36.29 | -19.16 | 18.18 | 8.27 | Upgrade
|
| Change in Other Net Operating Assets | -4.92 | 2.28 | 29.14 | -3.9 | -0.06 | Upgrade
|
| Operating Cash Flow | 171.95 | 111.09 | 116.83 | 127.13 | 138.4 | Upgrade
|
| Operating Cash Flow Growth | 54.79% | -4.91% | -8.10% | -8.14% | -3.30% | Upgrade
|
| Capital Expenditures | -0.73 | -0.55 | -0.41 | -2.05 | -3.69 | Upgrade
|
| Cash Acquisitions | - | - | - | -311.69 | -298.54 | Upgrade
|
| Investment in Securities | -189.14 | 269.28 | -216.25 | 231.82 | 267.53 | Upgrade
|
| Investing Cash Flow | -189.87 | 268.73 | -216.66 | -81.91 | -34.7 | Upgrade
|
| Short-Term Debt Issued | - | 93 | - | - | - | Upgrade
|
| Long-Term Debt Issued | - | - | - | 0.8 | - | Upgrade
|
| Total Debt Issued | - | 93 | - | 0.8 | - | Upgrade
|
| Short-Term Debt Repaid | - | -93 | - | - | - | Upgrade
|
| Long-Term Debt Repaid | - | -402.5 | - | -138.32 | -0.8 | Upgrade
|
| Total Debt Repaid | - | -495.5 | - | -138.32 | -0.8 | Upgrade
|
| Net Debt Issued (Repaid) | - | -402.5 | - | -137.52 | -0.8 | Upgrade
|
| Issuance of Common Stock | 14.91 | 6.61 | 12.42 | 7.1 | 4.36 | Upgrade
|
| Repurchase of Common Stock | -2.72 | -1.99 | - | - | - | Upgrade
|
| Other Financing Activities | - | - | -22.9 | - | - | Upgrade
|
| Financing Cash Flow | 12.19 | -397.88 | -10.48 | -130.42 | 3.56 | Upgrade
|
| Net Cash Flow | -5.72 | -18.07 | -110.31 | -85.21 | 107.26 | Upgrade
|
| Free Cash Flow | 171.23 | 110.53 | 116.41 | 125.08 | 134.71 | Upgrade
|
| Free Cash Flow Growth | 54.91% | -5.05% | -6.93% | -7.15% | -4.96% | Upgrade
|
| Free Cash Flow Margin | 25.87% | 18.19% | 17.45% | 21.57% | 25.89% | Upgrade
|
| Free Cash Flow Per Share | 3.06 | 1.99 | 1.89 | 2.30 | 2.51 | Upgrade
|
| Cash Interest Paid | - | 1.95 | 2.52 | 2.52 | 2.52 | Upgrade
|
| Cash Income Tax Paid | 53.25 | 36.6 | 16.2 | 25.19 | 45.43 | Upgrade
|
| Levered Free Cash Flow | 155.22 | 161.71 | 89.54 | 116.37 | 137.93 | Upgrade
|
| Unlevered Free Cash Flow | 155.22 | 162.69 | 91.84 | 113.51 | 136.2 | Upgrade
|
| Change in Net Working Capital | -9.42 | -43.24 | 39.37 | -15.37 | 4.57 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.